Long-Term Outcomes After Treatment of Delirium During Critical Illness With Antipsychotics
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial
Lancet Respir Med 2024 Apr 30;[EPub Ahead of Print], MF Mart, LM Boehm, AL Kiehl, MN Gong, A Malhotra, RL Owens, BA Khan, MA Pisani, GA Schmidt, RD Hite, MC Exline, SS Carson, CL Hough, P Rock, IS Douglas, DJ Feinstein, RC Hyzy, WD Schweickert, DL Bowton, A Masica, OM Orun, R Raman, BT Pun, C Strength, ML Rolfsen, PP Pandharipande, NE Brummel, CG Hughes, MB Patel, JL Stollings, EW Ely, JC Jackson, TD GirardFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.